Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plozasiran in Adults With Hypertriglyceridemia
NCT06347133Phase 3Completed
- Sponsor
- Arrowhead Pharmaceuticals
- Start
- May 2024
- Primary completion
- Jun 2026
- Modality
- Conjugated siRNA, Chemically Modified siRNA
- Countries
- 15
01
Overview
A Phase 3 trial of plozasiran in hypertriglyceridemia, sponsored by Arrowhead Pharmaceuticals. Started May 2024; status: completed.
02
Drugs
plozasiran
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT06347133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06347133.